查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586001

COVID-19 检测市场：按套件类型、测试类型、检体类型、应用划分 - 2025-2030 年全球预测

COVID-19 Testing Market by Kit Type (Rapid Test Kit, Real-Time Reverse Transcription Polymerase Chain Reaction ), Test Type, Specimen Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年，COVID-19 测试市场估值为 388.4 亿美元，预计到 2024 年将达到 426.2 亿美元，复合年增长率为 10.20%，预计到 2030 年将达到 766.9 亿美元。

COVID-19 检测市场的范围和定义包括用于检测个人 SARS-CoV-2 病毒的诊断工具的生产和分销。该市场主要包括PCR检测、抗原检测和抗体检测，旨在快速诊断感染，以进行病毒分离、治疗和预防传播。人们强调，COVID-19 检测是疫情期间公共卫生管理的重要工具，不仅在医疗保健领域，而且在确保职场和社区安全运作的经济活动中也产生了影响。测试应用不仅限于临床环境，还渗透到旅行、娱乐、教育和职场等领域，展示了广泛的最终用途。

主要市场统计
基准年[2023] 388.4亿美元
预测年份 [2024] 426.2亿美元
预测年份 [2030] 766.9亿美元
复合年增长率（%） 10.20%

市场开拓洞察表明，由于对公共卫生的日益关注以及政府对开发更有效率、更快速的诊断测试的支持等因素，预计将出现强劲增长。尤其是，诸如家用检测套组、用于高效结果管理的数位健康整合以及使用可穿戴生物感测器的新型测试等创新测试技术的潜在商机已经成熟。然而，挑战仍然存在，包括测试准确性的变化、供应链限制以及市场进入的监管障碍，这可能会影响市场扩张。此外，获得测试机会的差异仍然是影响整体测试市场渗透率的重大问题。

创新机会在于开发更具成本效益、更快且更易于存取的测试解决方案，重点是易于分散的 POC 系统。人工智慧和机器学习也有成长潜力，可以增强资料解释，以及用于远端监控和测试的远端医疗系统。市场动态具有适应性，本质上是动态和竞争的，受到监管变化、技术进步、新变体和公共卫生政策导致的需求变化的影响。为了实现永续成长，企业必须提高供应链弹性，扩大检测物流的数位基础设施，并为多样化的检测解决方案建立合作伙伴关係，以满足新出现的公共卫生需求。

市场动态：揭示快速发展的 COVID-19 检测市场的关键市场洞察

COVID-19 检测市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球 COVID-19 感染患者数量增加
    • 政府越来越主动实施大规模测试
    • 积极努力生产改良的 COVID-19检测套组
  • 市场限制因素
    • 担心诊断试剂套件短缺
  • 市场机会
    • 新参与企业专注于家庭测试并整合先进软体
    • COVID-19 检测设备的开发与创新
  • 市场挑战
    • 测试结果不正确的问题

波特五力：驾驭 COVID-19 检测市场的策略工具

波特五力框架是了解 COVID-19 测试市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解 COVID-19 检测市场的外部影响

外部宏观环境因素在塑造 COVID-19 测试市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解 COVID-19 检测市场的竞争格局

对 COVID-19 测试市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 COVID-19 测试市场供应商的绩效评估

FPNV 定位矩阵是评估 COVID-19 测试市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了在 COVID-19 测试市场中的成功之路

对于旨在加强其在全球市场的影响力的公司来说，COVID-19 检测市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球新冠肺炎 (COVID-19) 感染人数不断增加
      • 政府加大力度进行大规模检测
      • 大量投资生产改良的 COVID-19检测套组
    • 抑制因素
      • 担心诊断试剂套件短缺
    • 机会
      • 新参与企业专注于家庭测试和高级软体集成
      • COVID-19检测设备的开发与创新
    • 任务
      • 测试结果不正确的问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章 按套件类型分類的 COVID-19 测试市场

  • 快速检测套组
  • 即时逆转录聚合酵素链锁反应(RT-PCR)

第 7 章 按测试类型分類的 COVID-19 测试市场

  • 多重NAAT
  • NAAT照护现场
  • 单重核酸增幅检查

第八章 COVID-19 测试市场样本类型

  • 血
  • 鼻拭子
  • 鼻咽拭子
  • 口咽拭子
  • 尿

第 9 章 COVID-19 测试市场：按应用分类

  • 诊所
  • 诊断中心
  • 医院

第 10 章 美洲的 COVID-19 检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区 COVID-19 检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的COVID-19检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AccuBioTech Co. Ltd.
  • ADT Biotech
  • AIVD Biotech Inc.
  • Altona Diagnostics GmbH
  • AMEDA Labordiagnostik GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cepheid Inc.
  • Coris BioConcept SPRL
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • GenBody America, LLC
  • Genuine Biosystem Pvt. Ltd.
  • Hologic Inc.
  • LAB-CARE DIAGNOSTICS（INDIA）PVT. LTD.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation
  • PerkinElmer Inc.
  • Quest Diagnostics Inc.
  • Quidel Corporation
  • SD Biosensor, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-02026C4C986E

The COVID-19 Testing Market was valued at USD 38.84 billion in 2023, expected to reach USD 42.62 billion in 2024, and is projected to grow at a CAGR of 10.20%, to USD 76.69 billion by 2030.

The scope and definition of the COVID-19 testing market encompass the production and distribution of diagnostic tools used to detect the SARS-CoV-2 virus in individuals. This market primarily includes PCR tests, antigen tests, and antibody tests, structured to promptly diagnose infection for timely isolation, treatment, and prevention of virus transmission. The necessity of COVID-19 testing was highlighted during the pandemic as a crucial tool in managing public health, supporting not just the healthcare sector but also influencing economic activities by ensuring workplaces and communities can function safely. Testing applications extend beyond clinical settings, permeating sectors such as travel, entertainment, education, and workplaces, marking its widespread end-use scope.

KEY MARKET STATISTICS
Base Year [2023] USD 38.84 billion
Estimated Year [2024] USD 42.62 billion
Forecast Year [2030] USD 76.69 billion
CAGR (%) 10.20%

Market insights indicate robust growth driven by factors such as a heightened public health focus and government support for developing more efficient and rapid diagnostic tests. There's a conducive environment for potential opportunities, particularly in innovative testing technologies like at-home testing kits, digital health integration for efficient results management, and novel test types using wearable biosensors. However, challenges endure, including variability in test accuracy, supply chain constraints, and regulatory hurdles in market entry, which may impact market expansion. Furthermore, disparities in testing access remain a critical issue affecting overall testing market penetration.

Innovation opportunities lie in developing more cost-effective, rapid, and accessible testing solutions, with emphasis on easy-to-distribute Point-of-Care systems. There's also potential growth in artificial intelligence and machine learning to enhance data interpretation and in telehealth systems for remote monitoring and testing. The COVID-19 testing market is adaptive, with a dynamic and competitive nature influenced by regulatory changes, technological advancements, and fluctuating demand driven by new variants and public health policies. For sustained growth, businesses should focus on improving supply chain resilience, expanding digital infrastructure for testing logistics, and forging collaborations for diversified testing solutions to cater to emergent public health needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COVID-19 Testing Market

The COVID-19 Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of COVID-19-infected patients globally
    • Rising government initiatives toward the implementation of mass testing
    • Significant invetsments to manufacture improved COVID-19 testing kits
  • Market Restraints
    • Concerns associated with scarcity of diagnostic kits
  • Market Opportunities
    • Focus of new entrants toward at-home testing and integration of advanced software
    • Development and innovations in COVID-19 testing devices
  • Market Challenges
    • Issues pertaining to false test results

Porter's Five Forces: A Strategic Tool for Navigating the COVID-19 Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COVID-19 Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COVID-19 Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COVID-19 Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COVID-19 Testing Market

A detailed market share analysis in the COVID-19 Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COVID-19 Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COVID-19 Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COVID-19 Testing Market

A strategic analysis of the COVID-19 Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COVID-19 Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co. Ltd., ADT Biotech, AIVD Biotech Inc., Altona Diagnostics GmbH, AMEDA Labordiagnostik GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cepheid Inc., Coris BioConcept SPRL, Danaher Corporation, F. Hoffmann-La Roche AG, GenBody America, LLC, Genuine Biosystem Pvt. Ltd., Hologic Inc., LAB-CARE DIAGNOSTICS (INDIA) PVT. LTD., Laboratory Corporation of America Holdings, Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Inc., Quidel Corporation, SD Biosensor, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the COVID-19 Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Kit Type, market is studied across Rapid Test Kit and Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR).
  • Based on Test Type, market is studied across Multiplex NAATs, NAAT Point of Care, and Singleplex Nucleic Acid Amplification Tests.
  • Based on Specimen Type, market is studied across Blood, Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab, and Urine.
  • Based on Application, market is studied across Clinics, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of COVID-19-infected patients globally
      • 5.1.1.2. Rising government initiatives toward the implementation of mass testing
      • 5.1.1.3. Significant invetsments to manufacture improved COVID-19 testing kits
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with scarcity of diagnostic kits
    • 5.1.3. Opportunities
      • 5.1.3.1. Focus of new entrants toward at-home testing and integration of advanced software
      • 5.1.3.2. Development and innovations in COVID-19 testing devices
    • 5.1.4. Challenges
      • 5.1.4.1. Issues pertaining to false test results
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. COVID-19 Testing Market, by Kit Type

  • 6.1. Introduction
  • 6.2. Rapid Test Kit
  • 6.3. Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)

7. COVID-19 Testing Market, by Test Type

  • 7.1. Introduction
  • 7.2. Multiplex NAATs
  • 7.3. NAAT Point of Care
  • 7.4. Singleplex Nucleic Acid Amplification Tests

8. COVID-19 Testing Market, by Specimen Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Nasal Swab
  • 8.4. Nasopharyngeal Swab
  • 8.5. Oropharyngeal Swab
  • 8.6. Urine

9. COVID-19 Testing Market, by Application

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas COVID-19 Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific COVID-19 Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa COVID-19 Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AccuBioTech Co. Ltd.
  • 3. ADT Biotech
  • 4. AIVD Biotech Inc.
  • 5. Altona Diagnostics GmbH
  • 6. AMEDA Labordiagnostik GmbH
  • 7. Becton, Dickinson and Company
  • 8. Bio-Rad Laboratories, Inc.
  • 9. bioMerieux SA
  • 10. Cepheid Inc.
  • 11. Coris BioConcept SPRL
  • 12. Danaher Corporation
  • 13. F. Hoffmann-La Roche AG
  • 14. GenBody America, LLC
  • 15. Genuine Biosystem Pvt. Ltd.
  • 16. Hologic Inc.
  • 17. LAB-CARE DIAGNOSTICS (INDIA) PVT. LTD.
  • 18. Laboratory Corporation of America Holdings
  • 19. Luminex Corporation
  • 20. PerkinElmer Inc.
  • 21. Quest Diagnostics Inc.
  • 22. Quidel Corporation
  • 23. SD Biosensor, Inc.
  • 24. Siemens Healthineers AG
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. COVID-19 TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. COVID-19 TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COVID-19 TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COVID-19 TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COVID-19 TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COVID-19 TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COVID-19 TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COVID-19 TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2023